Biotechnology firm Iovance Biotherapeutics, Inc. (NASSAQ: IOVA) is facing a securities class action lawsuit in the Northern District of California, alleging that the company misled investors about its ...

Today’s Forbes Daily newsletter covers Elon’s pledge to Tesla, a big mortgage bill for Trump, top employers for college grads ...